Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05740982 |
| Consolidated Lead Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 450 participants (ACTUAL) |
| Registered Start Date | 2023-03-22 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Emory Winship Cancer Institute | Atlanta, GA | Open Hospital Dossier -> |
| Brigham and Women's Hospital | Boston, MA | Open Hospital Dossier -> |
| Washington University and Siteman Cancer Center | Saint Louis, MO | Open Hospital Dossier -> |
| University of Rochester Medical Center | Rochester, NY | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.